During the workshop session on the afternoon of May 7, delegates will have the opportunity to attend up to 3 of the 60-minute workshops in person.
Workshops include:
- Aptar Pharma, “SmartTrack: Combining In Vitro And In Silico Tools to De-Risk the Development of a High Payload DPI”
- Catalent, “Practical Considerations for Development and Scale-up of Spray Dried Inhalation Powders”
- Copley Scientific, “Automating Inhaled and Nasal Product Testing: Lower Variability, Higher Productivity”
- Honeywell and Recipharm, “Manufacturing pMDIs using Ultra-low Global Warming Potential Propellant HFO-1234ze(E)”
- H&T Presspart, “A Modular Approach to Understand the Design Space of a Capsule-based High-performance Dry Powder Inhaler”
- Intertek, “Exploring In-Vitro Only Bioequivalence Pathways for Generic Nasal Suspensions”
- Kindeva, “Considering a Green pMDI?: Q&A to Navigate an Evolving Regulatory Landscape”
- PARI, “Optimizing Delivery Efficiency And Short Treatment Times During Nebulizer Therapy”
Other workshops include “Build Your Own Soft Mist Inhaler,””Nasal Powders: From Formulation and Process Development to Analytical Characterization,” “Integrated Carrier-based Formulation Development: Process and Performance Considerations,” and “Blending Optimization in Multi-component DPI Formulations.”
The program will also include presentation of the 2024 Charles G. Thiel Award and the VCU RDD Peter R. Byron Graduate Student Award; the usual Wednesday morning break for recreation; and networking opportunities. In addition to refreshment breaks and lunches during the day, cocktail receptions will take place each evening, and a dinner with dancing with follow the cocktail reception on the evening of May 8.
Although the podium presentations will not be live-streamed this year, recordings of talks will be made available on demand to registered delegates after the meeting until June 30. Many of the workshop presenters and poster authors will also record presentations that will be available to delegates on demand. An “on demand access only” registration is available for those unable to attend the meeting in person.
Conference sponsors for RDD 2024 are: Aptar Pharma, Honeywell, Kindeva, and Recipharm
According to Dalby, demand for exhibition tables has been strong and only a few spaces remain available. Approximately one quarter of the companies showing off products and services at RDD 2024 will be first-time exhibitors. Many of those new exhibitors are Asian companies, which Dalby attributes to the globalization of the market and demand related to the LGWP transition. With a full technology exhibit in addition to a large poster exhibit, he says, the conference will be using all of the rooms available at the hotel provide sufficient space for browsing.
Exhibitors currently scheduled for RDD 2024 include:
